Literature DB >> 13906375

Parstelin in anxiety states and depression.

R E HEMPHILL, A R FOSTER.   

Abstract

Entities:  

Keywords:  ANXIETY/therapy; CYCLOPROPANE/related compounds; DEPRESSION/therapy; MONOAMINE OXIDASE INHIBITORS/therapy; TRANQUILIZING AGENTS/therapy

Mesh:

Substances:

Year:  1962        PMID: 13906375      PMCID: PMC1903319     

Source DB:  PubMed          Journal:  J Coll Gen Pract        ISSN: 0307-4749


× No keyword cloud information.
  3 in total

1.  Treatment of depression-anxiety in office patients with combination of tranylcypromine and trifluoperazine.

Authors:  E J BACSIK
Journal:  Dis Nerv Syst       Date:  1960-11

2.  The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).

Authors:  B C SCHIELE
Journal:  Am J Psychiatry       Date:  1960-09       Impact factor: 18.112

3.  Clinical Evaluation of a New Antidepressant Agent: Tranylcypromine with Trifluoperazine (Parstelin).

Authors:  M Straker
Journal:  Can Med Assoc J       Date:  1960-12-17       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.